:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Lin‐Zhu Zhang, Xu He, Hai‐Dong Zhu
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	MedComm
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/mco2.607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
by: Yu Wu, et al.
Published: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
by: Shiqi Li, et al.
Published: (2024)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
by: Changping Deng, et al.
Published: (2025)

Targets of tumor microenvironment for potential drug development
by: Ling Zhang, et al.
Published: (2024)

Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
by: Yunfang Yu, et al.
Published: (2024)

Natural killer cells in cancer immunotherapy
by: DanRu Wang, et al.
Published: (2024)

New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
by: Sha Qin, et al.
Published: (2024)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
by: Yalun Li, et al.
Published: (2024)

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
by: Junshu Li, et al.
Published: (2024)

Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
by: Jinwei Li, et al.
Published: (2024)

Exosomes: a double‐edged sword in cancer immunotherapy
by: Jiayi Chen, et al.
Published: (2025)

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy
by: Junyu Wang, et al.
Published: (2024)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
by: Xiaoting Luo, et al.
Published: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
by: Zheng Liu, et al.
Published: (2025)

Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
by: Yuqing Zhao, et al.
Published: (2024)

Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy
by: Qin Wang, et al.
Published: (2024)

PGE2‐EP2/EP4 axis: A new perspective on cancer immunotherapy
by: Lin Chen, et al.
Published: (2024)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
by: Zhijun Yuan, et al.
Published: (2024)

Fc‐null anti‐CTLA‐4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis‐inducing mishap
by: Jingjing Chen, et al.
Published: (2024)

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1
by: Yalei Wen, et al.
Published: (2025)

Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor‐mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation
by: Fuyan Xu, et al.
Published: (2024)

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges
by: Jie Xu, et al.
Published: (2024)

Cancer‐Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy
by: Chang Fan, et al.
Published: (2025)

Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
by: Fang‐Zheng Qi, et al.
Published: (2024)

Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
by: Fei Wang, et al.
Published: (2024)

Targeting the DNA damage response in cancer
by: Federica Guffanti, et al.
Published: (2024)

Nanoparticle‐encapsuled celastrol‐Fe(III): “Single‐edged sword” for tumor therapy featuring microenvironment‐dependent toxicity
by: Yu Liu, et al.
Published: (2024)

Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer
by: Nan Liu, et al.
Published: (2025)

Tyrosine phosphatase SHP2 aggravates tumor progression and glycolysis by dephosphorylating PKM2 in gastric cancer
by: Peiyun Wang, et al.
Published: (2024)

Interplay of IL‐17A/IL‐17RA signaling with microbial homeostasis in systemic anti‐tumoral responses
by: Shi‐jun He, et al.
Published: (2024)

Crizotinib: A Novel Strategy to Reverse Immunosuppression in Melanoma by Targeting Lactate Transport
by: Zhe Zhou, et al.
Published: (2025)

Inducing disulfidptosis in tumors:potential pathways and significance
by: Tao Mi, et al.
Published: (2024)

Precise tumor treatment: pH‐responsive nanoparticles for modulating and real‐time monitoring tumor microenvironment
by: Xinming Su, et al.
Published: (2024)

An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
by: Modan Yang, et al.
Published: (2024)

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets
by: Qianying Ouyang, et al.
Published: (2026)

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets
by: Xiaodie Liu, et al.
Published: (2026)

Targeting the miR‐96‐5p/Cathepsin B Pathway to Alleviate Neuron‐Derived Neuroinflammation in Alzheimer's Disease
by: Kai Zheng, et al.
Published: (2025)

Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application
by: Chenghao Cao, et al.
Published: (2025)

Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2
by: Danyi Wang, et al.
Published: (2024)

CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
by: Zitong Zhao, et al.
Published: (2024)